PROVISION OF FINANCIAL ASSISTANCE

SUNZEN BIOTECH BERHAD

Type Announcement
Subject PROVISION OF FINANCIAL ASSISTANCE
Description
SUNZEN BIOTECH BERHAD ("THE COMPANY" OR "SUNZEN") 
PROVISION OF FINANCIAL ASSISTANCE PURSUANT TO RULE 8.25(1)(ii) AND GUIDANCE NOTE 4 OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD ("LISTING REQUIREMENTS")
Pursuant to Rule 8.25(1)(ii) and Guidance Note 4 of the Listing Requirements, the Board of Directors of Sunzen wishes to announce the aggregate amount of financial assistance provided by its wholly-owned subsidiary, Finsource Credit (M) Sdn. Bhd. (“Finsource”), a moneylending company in the ordinary course of its business for the financial quarter ended 30 September 2024 as set out below:

Type of Financial Assistance
Amount
(RM)
Loans extended to customers in the ordinary course of Finsource’s business, inclusive of the future interest income of RM33,458,966
95,262,776
Total
95,262,776

The provision of financial assistance as set out above have no significant impact on the net assets and earnings per share of Sunzen Group for the period ended 30 September 2024.


The details of the provision of financial assistance pursuant to Rule 8.25(2)(e) of the Listing Requirements are set out in the attachment.


This announcement is dated 22 November 2024.





Announcement Info

Company Name SUNZEN BIOTECH BERHAD
Stock Name SUNZEN
Date Announced 22 Nov 2024
Category General Announcement for PLC
Reference Number GA1-20112024-00065